Skip to content
Neural Daily

PolicyNews

UK launches AI Biosecurity Lab with up to £300M

🇭🇺 Olvasd el magyarul →

The UK government is setting up the AI Biosecurity Lab to use frontier AI for earlier detection of biological threats. £100 million in public money is joined by up to £200 million from OpenAI and Anthropic.

By: Mikola Máté Patrik · · 2 min read

GOV.UK news page announcing the AI Biosecurity Lab, published by the Cabinet Office on 24 October 2026
Image: GOV.UK · Screenshot · Screenshot of the official GOV.UK announcement page · Source

What was announced?

On October 24, the UK Cabinet Office announced the AI Biosecurity Lab (AIBL) (GOV.UK), which the government calls the world's first dedicated AI biosecurity organisation. It is part of a National AI Biosecurity Initiative.

The rationale cuts both ways: AI can speed up research and the development of new countermeasures, while increasingly capable models could also lower barriers to harmful biological activity.

Who is putting in what?

  • The UK government provides £100 million.
  • OpenAI provides £100 million in compute and model credits, plus trusted access to its most capable relevant models through the Rosalind Biodefense programme.
  • Anthropic provides up to £100 million in model credits, trusted model access and dedicated technical support.
  • Google DeepMind will partner on research and look to provide trusted access to frontier Gemini and specialised science models. UK company Basecamp Research contributes its AI-biology models and expertise.

The company contributions are mostly credits and model access rather than cash. The government also intends to bring in philanthropic funding over time.

What will it work on?

Initial delivery focuses on two areas: earlier detection of emerging biological threats, and faster development of vaccines, treatments and other medical countermeasures.

How will it run?

AIBL will operate as an independent non-profit, modelled on the AI Security Institute. It will work with the UK Health Security Agency (UKHSA), the Animal and Plant Health Agency (APHA) and the Defence Science and Technology Laboratory (Dstl), and with the MHRA to inform the regulation of AI-designed medicines. A scientific advisory committee will be set up, with details to follow.

Why it matters

Frontier labs have mostly handled biological risk through their own safeguards. Here, a government-backed body gets access to the strongest models for defensive work. The announcement names no leader, location or start date yet, so those details are the next thing to watch.

    Produced with the help of AI, reviewed by an editor. How we make our articles

    Reviewed and edited by the Neural Daily desk. About

    Related articles